Evaluation of Tumor Budding In Colorectal Adenocarcinoma

Launched by SOHAG UNIVERSITY · May 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a feature called tumor budding in colorectal adenocarcinoma, which is a type of colon cancer. Tumor budding refers to tiny clusters of cancer cells at the edge of a tumor and can provide important information about how aggressive the cancer is and how likely it is to come back after treatment. By evaluating tumor budding, researchers hope to improve predictions about patient outcomes and help guide treatment decisions.

To participate in this trial, individuals need to have tissue samples from their colorectal cancer that are in good condition and come with enough clinical information. Unfortunately, samples that are damaged or lack sufficient data will not be included. The trial is not yet recruiting participants, and it aims to involve people of all genders and a wide age range. If you or a loved one is considering participation, you'll be contributing to important research that could potentially improve future care for colorectal cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Specimens from patients with Colorectal Carcinoma. Tissue blocks with sufficient material. Specimens with sufficient clinical data.
• Exclusion Criteria:
• • Tissue blocks with insufficient, destroyed or necrotic material. Specimens with insufficient clinical data.